Rxulti is an antipsychotic medicine used to treat schizophrenia in adults and adolescents from 13 years of age. Schizophrenia is a mental illness with symptoms such as delusions, disorganised thinking and speech, suspiciousness and hallucinations (seeing, hearing or feeling things that are not there). Rxulti contains the active substance brexpiprazole.
Therapeutic Indication
### Therapeutic indication Rxulti is indicated for the treatment of schizophrenia in adult and adolescents aged 13 years and older.
Therapeutic Area (MeSH)
ATC Code
N05AX16
ATC Item
brexpiprazole
Pharmacotherapeutic Group
Psycholeptics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| brexpiprazole | N/A | 布瑞哌唑 |
EMA Name
Rxulti
Medicine Name
Rxulti
Aliases
N/A
